Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

RhoBTB2 in breast cancer

Authors: CM McKinnon, H Mellor

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

Rho GTPases have multiple roles in cancer. We are working to characterise the novel Rho GTPase RhoBTB2/DBC2, which has been reported to be a tumour suppressor in breast cancer. …
Metadata
Title
RhoBTB2 in breast cancer
Authors
CM McKinnon
H Mellor
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2516

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Poster presentation

Reduced MCPH1 expression in breast cancer and response to chemotherapy

Poster presentation

Recruitment of insulin receptor substrate-1 by erbB3 impacts on IGF-IR signalling in oestrogen receptor-positive breast cancer cells

Poster presentation

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer

Poster presentation

Anti-HER2 imaging agents for breast cancer imaging

Poster presentation

Intensity and features of acute postoperative pain after mastectomy and breast-conserving surgery

Poster presentation

Modelling breast cancer in a three-dimensional heterotypic culture system
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits